GCP
CNMD icon

Gill Capital Partners’s CONMED CNMD Stock Holding History

Gill Capital Partners’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.18K Hold
250
– – ﹤0.01% 473
2026
Q1 		$8.84K Buy
+250
New +$10.2K ﹤0.01% 453

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Gill Capital Partners's CNMD Position: Q2 2026 in Review

Gill Capital Partners held its CONMED (CNMD) position steady in Q2 2026 at 250 shares worth $8.18K. The position accounts for ﹤0.01% of the portfolio, ranked #473.

Gill Capital Partners first reported a position in CNMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $8.84K in Q1 2026. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Gill Capital Partners held 250 shares of CONMED worth $8.18K as of Q2 2026.
  • Gill Capital Partners left its CONMED share count unchanged in Q2 2026.
  • CONMED made up ﹤0.01% of Gill Capital Partners's portfolio in Q2 2026, its #473 holding.
  • Gill Capital Partners first reported a position in CONMED in Q1 2026 and has held it in 2 quarters since.
  • Gill Capital Partners's CONMED position peaked at $8.84K in Q1 2026.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.